Combined effects of vitamin D3 and dioxopiperidinamide derivative on lipid homeostasis, inflammatory pathways, and redox imbalance in non‐alcoholic fatty liver disease in vivo zebrafish model
Biotechnology and Applied Biochemistry · 2025-04 · 72 (2) · 320-339
DOI: 10.1002/bab.2666 ↗At a glance
Journal article in Biotechnology and Applied Biochemistry, published online on 2024-09-09. Written by Santhanam Sanjai Dharshan and 9 co-authors. Institution: Toxicology and Pharmacology Laboratory, Department of Biotechnology, Faculty of Science and Humanities, SRM Institute of Science and Technology, Katt…. Major MEDLINE topics: Non-alcoholic Fatty Liver Disease, Cholecalciferol, Lipid Metabolism, Inflammation. Cited 29 times so far (Crossref); 56 references.
Abstract (original language)
Liver damage and metabolic dysfunctions, the defining features of non‐alcoholic fatty liver disease (NAFLD), are marked by inflammation, oxidative stress, and excessive hepatic fat accumulation. The current therapeutic approaches for NAFLD are limited, necessitating exploring novel treatment strategies. Dioxopiperidinamide derivatives, particularly DOPA‐33, have shown effective anti‐inflammatory and antioxidant properties, potentially offering therapeutic benefits against NAFLD. This study investigated the combined potential of vitamin D 3 (Vit D 3 ) and DOPA‐33 in treating NAFLD. The network pharmacology analysis identified key NAFLD targets modulated by Vit D3 and DOPA‐33, emphasizing their potential mechanisms of action. In NAFLD‐induced zebrafish models, Vit D 3 and DOPA‐33 significantly reduced hepatic lipid accumulation, oxidative stress, and apoptosis, demonstrating superior efficacy over individual treatments. The treatment also lowered reactive oxygen species (ROS) levels, decreased liver damage, and enhanced antioxidant defense mechanisms. Moreover, behavioral analyses showed improved locomotion and reduced weight gain in treated zebrafish. Biochemical analyses revealed lower triglycerides (TG) and glucose levels with improved oxidative markers. Furthermore, histological analyses indicated reduced hepatic steatosis and inflammation, with decreased expression of lipogenesis‐related genes and inflammatory mediators. Finally, high‐performance liquid chromatography (HPLC) confirmed a significant reduction in hepatic cholesterol levels, indicating the effectiveness of the combination therapy in addressing key NAFLD‐related dyslipidemias. These findings suggest that Vit D 3 + DOPA‐33 targets pathways involved in lipid metabolism, inflammation, and oxidative stress by offering a promising therapeutic approach for NAFLD.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Toxicology and Pharmacology Laboratory, Department of Biotechnology, Faculty of Science and Humanities, SRM Institute of Science and Technology, Kattankulatur, Tamil Nadu, India.
- Department of Chemistry, College of Engineering and Technology, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu, India.
- Department of Pharmaceutical Analysis, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu, India.
- Department of Pharmacology, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu, India.
- Department of Botany and Microbiology, College of Science, King Saud University, Riyadh, Saudi Arabia.
- Centre for Applied Research, Saveetha School of Engineering, Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai, Tamil Nadu, India.
ORCID profiles: S Karthick Raja Namasivayam
Cite
APA
Dharshan, S. S., Ramamurthy, K., Kaliraj, S., Manikandan, K., Chitra, V., Rajagopal, R., Alfarhan, A., Namasivayam, S. K. R., Kathiravan, M. K., & Arockiaraj, J. (2025). Combined effects of vitamin D3 and dioxopiperidinamide derivative on lipid homeostasis, inflammatory pathways, and redox imbalance in non‐alcoholic fatty liver disease in vivo zebrafish model. Biotechnology and Applied Biochemistry, 72(2), 320-339. https://doi.org/10.1002/bab.2666
Vancouver
Dharshan SS, Ramamurthy K, Kaliraj S, Manikandan K, Chitra V, Rajagopal R, et al. Combined effects of vitamin D3 and dioxopiperidinamide derivative on lipid homeostasis, inflammatory pathways, and redox imbalance in non‐alcoholic fatty liver disease in vivo zebrafish model. Biotechnology and Applied Biochemistry. 2025;72(2):320-339. doi:10.1002/bab.2666
BibTeX
@article{Dharshan2025,
author = {Dharshan, Santhanam Sanjai and Ramamurthy, Karthikeyan and Kaliraj, Salamuthu and Manikandan, Krishnan and Chitra, Vellapandian and Rajagopal, Rajakrishnan and Alfarhan, Ahmed and Namasivayam, S Karthick Raja and Kathiravan, Muthu Kumaradoss and Arockiaraj, Jesu},
title = {Combined effects of vitamin D3 and dioxopiperidinamide derivative on lipid homeostasis, inflammatory pathways, and redox imbalance in non‐alcoholic fatty liver disease in vivo zebrafish model},
journal = {Biotechnology and Applied Biochemistry},
year = {2025},
volume = {72},
number = {2},
pages = {320--339},
doi = {10.1002/bab.2666}
}
EUVIMED